David J. Wambeke Dia Medica Therapeutics Inc. (DMAC) insider trading activity

David J. Wambeke is Chief Business Officer of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 527,114 shares of DMAC, which is worth approximately $3.12 Million. The most recent transaction as insider was on Nov 16, 2023, when has been sold 20,000 shares (Voting Common Shares, no par value per share) at a price of $2.46 per share, resulting in proceeds of $49,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 527K

0% 3M change

0% 12M change

Total Value Held $3.12 Million

David J. Wambeke Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 16 2023	BUY Open market or private purchase	$49,200 $2.46 p/Share	20,000 Added 3.66%	527,114 Voting Common Shares, ...
Jun 23 2023	BUY Open market or private purchase	$150,003 $3.91 p/Share	38,364 Added 7.03%	507,114 Voting Common Shares, ...
Apr 10 2023	BUY Open market or private purchase	$750,000 $1.6 p/Share	468,750 Added 50.0%	468,750 Voting Common Shares, ...

DJW

David J. Wambeke

Chief Business Officer

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC

Account